Evidence for a causal association between human papillomavirus and a subset of head and neck cancers

Journal of the National Cancer Institute

Volumn 92, Issue 9, 2000, Pages 709-720

  Gillison, Maura L ^a   Koch, Wayne M ^a   Capone, Randolph B ^a   Spafford, Michael ^a   Westra, William H ^a   Wu, Li ^a   Zahurak, Marianna L ^b   Daniel, Richard W ^c   Viglione, Michael ^a   Symer, David E ^a   Shah, Keerti V ^c   Sidransky, David ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; VIRUS DNA;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; CANCER RISK; CELLULAR DISTRIBUTION; CIGARETTE SMOKING; CONTROLLED STUDY; FEMALE; HEAD AND NECK CARCINOMA; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SQUAMOUS CELL CARCINOMA; TOBACCO; VIRUS CARCINOGENESIS; VIRUS DETECTION; VIRUS INFECTION; VIRUS STRAIN; WART VIRUS;

EID: 0034600339     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/92.9.709     Document Type: Article

References (96)

1. Franceschi S, Talamini R, Barra S, Baron AE, Negri E, Bidoli E, et al. Smoking and drinking in relation to cancers of the oral cavity, pharynx, larynx, and esophagus in northern Italy. Cancer Res 1990;50:6502-7.
2. Mashberg A, Boffetta P, Winkelman R, Garfinkel L. Tobacco smoking, alcohol drinking, and cancer of the oral cavity and oropharynx among U.S. veterans. Cancer 1993;72:1369-75.
3. Gillison M, Koch WM, Shah KV. Human papillomavirus and head and neck squamous cell carcinoma: are some head and neck cancers sexually transmitted disease? Curr Opin Oncol 1999;11:191-9.
4. Franceschi S, Munoz N, Bosch XF, Snijders PJ, Walboomers JM. Human papillomavirus and cancers of the upper aerodigestive tract: a review of epidemiological and experimental evidence. Cancer Epidemiol Biomarkers Prev 1996;5:567-75.
5. Scheffner M, Huibregtse JM, Vierstra RD, Howley PM. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 1993;75:495-505.
6. Galloway DA, McDougall JK. The disruption of cell cycle checkpoints by papillomavirus oncoproteins contributes to anogenital neoplasia. Semin Cancer Biol 1996;7:309-15.
7. Rapp L, Chen JJ. The papillomavirus E6 proteins. Biochem Biophys Acta 1998;1378:F1-19.
8. Jones DL, Munger K. Analysis of the p53-mediated G1 growth arrest pathway in cells expressing the human papillomavirus type 16 E7 oncoprotein. J Virol 1997;71:2905-12.
9. McDougall JK. Immortalization and transformation of human cells by human papillomavirus. Curr Top Microbiol Immunol 1994;186:101-19.
10. Califano J, van der Riet P, Westra W, Nawroz H, Clayman G, Piantadosi S, et al. Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res 1996;56:2488-92.
11. Sidransky D. Molecular genetics of head and neck cancer. Curr Opin Oncol 1995;7:229-33.
12. Liggett WH Jr, Sidransky D. Role of the p16 tumor suppressor gene in cancer. J Clin Oncol 1998;16:1197-206.
13. Reed AL, Califano J, Cairns P, Westra WH, Jones RM, Koch W, et al. High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma. Cancer Res 1996;56:3630-3.
14. Mounts P, Shah KV, Kashima H. Viral etiology of juvenile-and adult-onset squamous papilloma of the larynx. Proc Natl Acad Sci U S A 1982; 79:5425-9.
15. Steinberg BM, DiLorenzo TP. A possible role for human papillomaviruses in head and neck cancer. Cancer Metastasis Rev 1996;15:91-112.
16. Paz IB, Cook N, Odom-Maryon T, Xie Y, Wilczynski SP. Human papillomavirus (HPV) in head and neck cancer. An association of HPV 16 with squamous cell carcinoma of Waldeyer's tonsillar ring. Cancer 1997;79: 595-604.
17. Haraf DJ, Nodzenski E, Brachman D, Mick R, Montag A, Graves D, et al. Human papilloma virus and p53 in head and neck cancer: clinical correlates and survival. Clin Cancer Res 1996;2:755-62.
18. Niedobitek G, Pitteroff S, Herbst H, Shepherd P, Finn T, Anagnostopoulos I, et al. Detection of human papillomavirus type 16 DNA in carcinomas of the palatine tonsil. J Clin Pathol 1990;43:918-21.
19. Wilczynski SP, Lin BT, Xie Y, Paz IB. Detection of human papillomavirus DNA and oncoprotein overexpression are associated with distinct morphological patterns of tonsillar squamous cell carcinoma. Am J Pathol 1998; 152:145-56.
20. Snijders PJ, Cromme FV, van den Brule A, Schrijnemakers HF, Snow GB, Meijer CJ, et al. Prevalence and expression of human papillomavirus in tonsillar carcinomas, indicating a possible viral etiology. Int J Cancer 1992; 51:845-50.
21. Smith EM, Hoffman HT, Summersgill KS, Kirchner HL, Turek LP, Haugen TH. Human papillomavirus and risk of oral cancer. Laryngoscope 1998;108:1098-103.
22. Schwartz SM, Daling JR, Doody DR, Wipf GC, Carter JJ, Madeleine MM. et al. Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection. J Natl Cancer Inst 1998;90:1626-36.
23. Fleming I, Cooper J, Henson D, Hutter R, Kennedy B, Murphy G, et al. AJCC cancer staging manual. Philadelphia (PA): Lippincott-Raven; 1997.
24. Fearon ER, Feinberg AP, Hamilton SH, Vogelstein B. Loss of genes on the short arm of chromosome II in bladder cancer. Nature 1985;318:377-80.
25. Shanmugaratnam S. Histologic typing of tumors of the upper respiratory tract and ear. Geneva (Switzerland): World Health Organization; 1991.
26. Wain SL, Kier R, Vollmer RT, Bossen EH. Basaloid-squamous carcinoma of the tongue, hypopharynx, and larynx: report of 10 cases. Hum Pathol 1986;17:1158-66.
27. Baker CC, Phelps WC, Lindgren V, Braun MJ, Gonda MA, Howley PM. Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines. J Virol 1987;61:962-71.
28. Yee C, Krishnan-Hewlett I, Baker CC, Schlegel R, Howley PM. Presence and expression of human papillomavirus sequences in human cervical carcinoma cell lines. Am J Pathol 1985;119:361-6.
29. Schwarz E, Freese UK, Gissmann L, Mayer W, Roggenbuck B, Stremlau A, et al. Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature 1985;314:111-41.
30. Pater MM, Pater A. Human papillomavirus types 16 and 18 sequences in carcinoma cell lines of the cervix. Virology 1985;145:331-8.
31. Blin N, Stafford DW. A general method for isolation of high molecular weight DNA from eucaryotes. Nucleic Acids Res 1976;3:2303-8.
32. Huang CC, Qiu JT, Kashima ML, Kurman RJ, Wu TC. Generation of type-specific probes for the detection of single-copy human papillomavirus by a novel in situ hybridization method. Mod Pathol 1998;11:971-7.
33. Ting Y, Manos M. Detection and typing of genital human papillomaviruses. In: Innis M, Gelfand G, Sninsky J, editors. Polymerase chain reaction protocols: a guide to methods and applications. San Diego (CA): San Diego Academic Press; 1990. p. 356-67.
34. Hildesheim A, Schiffman MA, Gravitt PE, Glass AG, Greer CE, Zhang T, et al. Persistence of type-specific human papillomavirus infection among cytologically normal women. J Infect Dis 1994;169:235-40.
35. Torroella-Kouri M, Morsberger S, Carillo A. Mohar A, Meneses A, Ibarra M, et al. HPV prevalence among Mexican women with neoplastic and normal cervixes. Gynecol Oncol 1998;70:115-20.
36. Smith LM, Sanders JZ, Kaiser RJ, Hughes P, Dodd C, Connell C, et al. Fluorescence detection in automated DNA sequence analysis. Nature 1986; 321:674-9.
37. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah K, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12-9.
38. Yamada T, Wheeler CM, Halpern AL, Stewart AC, Hildesheim A, Jenison SA. Human papillomavirus type 16 variant lineages in United States populations characterized by nucleotide sequence analysis of the E6, L2, and L1 coding segments. J Virol 1995;69:7743-53.
39. Yamada T, Manos MM, Peto J, Greer CE, Munoz N, Bosch FX, et al. Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective. J Virol 1997;71:2463-72.
40. Sidransky D, Von Eschenbach A, Tsai YC, Jones P, Summerhayes I, Marshall F, et al. Identification of p53 gene mutations in bladder cancers and urine samples. Science 1991;252:706-9.
41. Buchman G, Schester D, Raschtas A. Rapid and efficient cloning of PCR products using the clone amp system. Focus 1992;14:41-5.
42. Hainaut P, Soussi T, Shomer B, Hollstein M, Greenblatt M, Hovig E, et al. Database of p53 gene somatic mutations in human tumors and cell lines: updated compilation and future prospects. Nucleic Acids Res 1997;25: 151-7.
43. Caron de Fromentel C, Soussi T. TP53 tumor suppressor gene: a model for investigating human mutagenesis. Genes Chromosomes Cancer 1992;4: 1-15.
44. Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
45. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959;22:719-48.
46. Cox D. Regression models and life tables. J R Stat Soc 1972;34:187-220.
47. Corporation SaER: EGRET users' manual. Seattle (WA): Statistics and Epidemiology Research Corporation; 1988.
48. Matsukura T, Koi S, Sugase M. Both episomal and integrated forms of human papillomavirus type 16 are involved in invasive cervical cancers. Virology 1989;172:63-72.
49. Cullen P, Reid R, Campion M, Lorincz A. Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasm. J Virol 1991;65:606-12.
50. Fouret P, Monceaux G, Temam S, Lacourreye L, St Guily JL. Human papillomavirus in head and neck squamous cell carcinomas in nonsmokers. Arch Otolaryngol Head Neck Surg 1997;123:513-6.
51. Brandsma JL, Abramson AL. Association of papillomavirus with cancers of the head and neck. Arch Otolaryngol Head Neck Surg 1989;115: 621-5.
52. Andl T, Kahn T, Pfuhl A, Nicola T, Erber R, Conradt C, et al. Etiological involvement of oncogenic human papillomavirus in tonsillar squamous cell carcinomas lacking retinoblastoma cell cycle control. Cancer Res 1998;58: 5-13.
53. Snijders PJ, Meijer CJ, van den Brule AJ. Schrijnemakers HF, Snow GB, Walboomers JM. Human papillomavirus (HPV) type 16 and 33 E6/E7 region transcripts in tonsillar carcinomas can originate from integrated and episomal HPV DNA. J Gen Virol 1992;73(Pt 8):2059-66.
54. Kahn T, Turazza E, Ojeda R, Bercovich A, Stremlau A, Lichter P, et al. Integration of human papillomavirus type 6a DNA in a tonsillar carcinoma: chromosomal localization and nucleotide sequence of the genomic target region. Cancer Res 1994;54:1305-12.
55. Steenbergen RD, Hermsen MA, Walboomers JM, Joenje H, Arwert F, Meijer CJ, et al. Integrated human papillomavirus type 16 and loss of heterozygosity at 11q22 and 18q21 in an oral carcinoma and its derivative cell line. Cancer Res 1995;55:5465-71.
56. Banks ER, Frierson HF Jr, Mills SE, George E, Zarbo RJ, Swanson PE. Basaloid squamous cell carcinoma of the head and neck. A clinicopathologic and immunohistochemical study of 40 cases. Am J Surg Pathol 1992; 16:939-46.
57. Raslan WF, Barnes L, Krause JR, Contis L, Killeen R, Kapadia SB. Basaloid squamous cell carcinoma of the head and neck: a clinicopathologic and flow cytometric study of 10 new cases with review of the English literature. Am J Otolaryngol 1994;15:204-11.
58. Barnes L, Ferlito A, Altavilla G, MacMillan C, Rinaldo A, Doglioni C. Basaloid squamous cell carcinoma of the head and neck: clinicopathological features and differential diagnosis. Ann Otol Rhinol Laryngol 1996; 105:75-82.
59. Williams GR, Lu QL, Love SB, Talbot IC, Northover JM. Properties of HPV-positive and HPV-negative anal carcinomas. J Pathol 1996;180: 378-82.
60. Cubilla AL, Reuter VE, Gregoire L, Ayala G, Ocampos S, Lancaster WD, et al. Basaloid squamous cell carcinoma: a distinctive human papilloma virus-related penile neoplasm. Am J Surg Pathol 1998;22:755-61.
61. Gregoire L, Cubilla AL, Reuter VE, Haas GP, Lancaster WD. Preferential association of human papillomavirus with high-grade histologic variants of penile-invasive squamous cell carcinoma. J Natl Cancer Inst 1995;87: 1705-9.
62. Trimble CL, Hildesheim A. Brinton LA, Shah KV, Kurman RJ. Heterogeneous etiology of squamous cell carcinoma of the vulva. Obstet Gynecol 1996;87:59-64.
63. Kurman RJ, Toki T, Schiffman MH. Basaloid and warty carcinomas of the vulva. Distinctive types of squamous cell carcinoma frequently associated with human papillomavirus. J Surg Pathol 1993;17:133-45.
64. Boyle JO, Hakim J, Koch W, van der Riet P, Hruban RH, Roa RA, et al. The incidence of p53 mutations increases with progression of head and neck cancer. Cancer Res 1993;53:4477-80.
65. Sauter ER, Cleveland D, Trock B, Ridge JA, Klein-Szanto AJ. p53 is overexpressed in fifty percent of pre-invasive lesions of head and neck epithelium. Carcinogenesis 1994;15:2269-74.
66. Crook T, Ludwig RL, Marston NJ, Willkomm D, Vousden KH. Sensitivity of p53 lysine mutants to ubiquitin-directed degradation targeted by human papillomavirus E6. Virology 1996;217:285-92.
67. Gardiol D, Banks L. Comparison of human papillomavirus type 18 (HPV-18) E6-mediated degradation of p53 in vitro and in viva reveals significant differences based on p53 structure and cell type but little difference with respect to mutants of HPV-18 E6. J Gen Virol 1998;79(Pt 8):1963-70.
68. Magal S, Jackman A, Pei XF, Schlegel R, Sherman L. Induction of apoptosis in human keratinocytes containing mutated p53 alleles and its inhibition by both the E6 and E7 oncoproteins. Int J Cancer 1998;75:96-104.
69. Song S, Gulliver GA, Lambert PF. Human papillomavirus type 16 E6 and E7 oncogenes abrogate radiation-induced DNA damage responses in vivo through p53-dependent and p53-independent pathways. Proc Natl Acad Sci U S A 1998;95:2290-5.
70. Munger K, Werness BA, Dyson N, Phelps W, Harlow E, Howley P. Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. EMBO J 1989;8:4099-105.
71. Park NH, Gujuluva CN, Baek JH, Cherrick HM, Shin KH, Min BM. Combined oral carcinogenicity of HPV-16 and benzo(a)pyrene: an in vitro multistep carcinogenesis model. Oncogene 1995;10:2145-53.
72. Garrett LR, Perez-Reyes N, Smith PP, McDougall JK. Interaction of HPV-18 and nitrosomethylurea in the induction of squamous cell carcinoma. Carcinogenesis 1993;14:329-32.
73. Liu X, Han S, Baluda M, Park NH. HPV-16 oncogenes E6 and E7 are mutagenic in normal human oral keratinocytes. Oncogene 1997;14: 2347-53.
74. Shin K, Tannyhill RJ, Liu X, Park NH. Oncogenic transformation of HPV-immortalized human oral keratinocytes is associated with the genetic instability of cells. Oncogene 1996;12:1089-96.
75. Begg CB, Zhang ZF. Statistical analysis of molecular epidemiology studies employing case-series. Cancer Epidemiol Biomarkers Prev 1994;3:173-5.
76. Snijders PJ, Scholes AG, Hart CA, Jones AS, Vaughan ED, Woolgar JA, et al. Prevalence of mucosotropic human papillomaviruses in squamous-cell carcinomas of the head and neck. Int J Cancer 1996;66:464-9.
77. Brandwein M, Zeitlin J, Nuovo GJ, MacConell P, Bodian C, Urken M, et al. HPV detection using "hot start" polymerase chain reaction in patients with oral cancer: a clinicopathologic study of 64 patients. Mod Pathol 1994;7:720-7.
78. Chiba I, Shindoh M, Yasuda M, Yamazaki Y, Amemiya A, Sato Y, et al. Mutations in the p53 gene and human papillomavirus infection as significant prognostic factors in squamous cell carcinomas of the oral cavity. Oncogene 1996;12:1663-8.
79. DeWeese TL, Walsh JC, Dillehay LE, Kessis TD, Hedrick L, Cho KR, et al. Human papillomavirus E6 and E7 oncoproteins alter cell cycle progression but not radiosensitivity of carcinoma cells treated with low-dose-rate radiation. Int J Radiat Oncol Biol Phys 1997;37:145-54.
80. Huang H, Li CY, Little JB. Abrogation of p53 function by transfection of HPV16 E6 gene does not enhance resistance of human tumor cells to ionizing radiation. Int J Radiat Biol 1996;70:151-60.
81. Rantanen V, Grenman S, Kurvinen K, Hietenen S, Raitanen M, Syrjanen S. p53 mutations and presence of HPV DNA do not correlate with radiosensitivity of gynecological cancer cell lines. Gynecol Oncol 1998;71:352-8.
82. Santin A, Hermonat PL, Ravaggi A, Chiriva-Internati M, Pecorelli S, Parham GP. Radiation-enhanced expression of E6/E7 transforming oncogenes of human papillomavirus-16 in human cervical carcinoma. Cancer 1998;83:2346-52.
83. Snijders PJ, Steenbergen RD, Top B, Scott SD, Meijer CJ, Walboomers JM. Analysis of p53 status in tonsillar carcinomas associated with human papillomavirus. J Gen Virol 1994;75(Pt 10):2769-75.
84. Scholes A, Liloglou T, Snijders PJ, Hart CA, Jones AS, Woolgar JA, et al. p53 mutations in relation to human papillomavirus type 16 infection in squamous cell carcinomas of the head and neck. Int J Cancer 1997;71: 796-9.
85. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah K, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12-9.
86. Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) study group. J Natl Cancer Inst 1995;87:796-803.
87. Xi LF, Koutsky LA, Galloway DA, Hughes JP, Wheeler CM, Holmes KK, et al. Genomic variation of human papillomavirus type 16 and risk for high grade cervical intraepithelial neoplasia. J Natl Cancer Inst 1997;89: 796-802.
88. Xi LF, Critchlow CW, Wheeler CM, Koutsky LA, Galloway DA, Kuypers J, et al. Risk of anal carcinoma in situ in relation to human papillomavirus type 16 variants. Cancer Res 1998;58:3839-44.
89. Zehbe I, Wilander E, Delius H, Tommasino M, Human papillomavirus 16 E6 variants are more prevalent in invasive cervical carcinoma than the prototype. Cancer Res 1998;58:829-33.
90. Stoppler MC, Ching K, Stoppler H, Clancy K, Schlegel R, Icenogle J. Natural variants of the human papillomavirus type 16 E6 protein differ in their abilities to alter keratinocyte differentiation and to induce p53 degradation. J Virol 1996;70:6987-93.
91. Watts DH, Koutsky LA, Holmes KK, Goldman D, Kuypers J, Kiviat NB, et al. Low risk of perinatal transmission of human papillomavirus: results from a prospective cohort study. Am J Obstet Gynecol 1998;178:365-73.
92. Koch A, Hansen SV, Nielsen NM, Palefsky J, Melbye M. HPV detection in children prior to sexual debut. Int J Cancer 1997;73:621-4.
93. Kellokoski JK, Syrjanen SM, Chang F, Yliskoski M, Syrjanen KJ. Southern blot hybridization and PCR detection of oral human papillomavirus (HPV) infections in women with genital HPV infections. J Oral Pathol Med 1992;21:459-64.
94. IARC: IARC monograph on the evaluation of carcinogenic risks to humans. Vol. 64. Human papillomaviruses. Lyon (France): International Agency for Research on Cancer; 1995.
95. Maden C, Beckmann AM, Thomas DB, McKnight B, Sherman KJ, Ashley RL, et al. Human papillomaviruses, herpes simplex viruses, and the risk of oral cancer in men. Am J Epidemiol 1992;135:1093-102.
96. Hill AB. The environment and disease: association or causation? Proc R Soc Med 1965;58:295-300.